Even before the United States entered into the era of the coronavirus illness (COVID-19), only 13 percent of the approximately 21 million people who needed treatment for a substance use disorder received it. Add to this the economic and social burdens facing Americans and this percentage has only likely decreased. With most states not covering a full panel of substance use disorder treatment through Medicaid, the response to opioid and other drug misuse has not been as strong as it could be. The  American Rescue Plan may offer hope. Read More

Deaths from drug overdoses were on the rise, even prior to coronavirus disease 2019 (COVID-19). And the pandemic has only amplified the issue. According to the US Centers for Disease Control and Prevention (CDC), “over 81,000 drug overdose deaths occurred in the US in the 12 months ending in May 2020, the highest number of overdose deaths ever recorded in a 12-month period.” In response to pandemic-induced rising overdoses, the federal government and partners have amplified programs to support local communities. Read More

Even prior to the pandemic, community-based pharmacies have been essential sources of care and support for families, especially those most in need of resources for accessing health care, food, financial assistance, etc. According to the Centers for Disease Control and Prevention, community pharmacies are located in most communities in the US and more than 90% of the US population live within 5 miles of one. They are frequented more than the primary care provider’s office and this has been further heightened by COVID-19. While traditional visits to the doctor or hospital have been hindered or moved to telehealth, the local pharmacy has been a source of not only pandemic-specific health and safety information, but also guidance for managing chronic diseases. Read More